Immunosuppressant Drugs Market (Drug Type - Calcineurin Inhibitors, Center for Biotechnology, Antiproliferative Agents, Imdh Inhibitors, and Other Drug Types; Route of Administration - Intravenous, Oral, and Other Routes; Application - Organ Transplant, Autoimmune Disease, Kidney Transplant, Liver Transplant, Heart Transplant, and Other Applications; End-user - Organ Transplant Centers, Hospitals and Clinics, and Other End-users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025. The global immunosuppressant drugs market is projected to grow at a CAGR of 4.9% over the forecast period of 2019-2025.

Pune, India -- (SBWire) -- 05/11/2020 --Infinium Global Research has recently published a global report on "Immunosuppressant Drugs Market (Drug Type - Calcineurin Inhibitors, Center for Biotechnology, Antiproliferative Agents, Imdh Inhibitors, and Other Drug Types; Route of Administration - Intravenous, Oral, and Other Routes; Application - Organ Transplant, Autoimmune Disease, Kidney Transplant, Liver Transplant, Heart Transplant, and Other Applications; End-user - Organ Transplant Centers, Hospitals and Clinics, and Other End-users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025."

To Know More Request Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/18729

Rise in the Number of Organ Transplantation Procedures

The rise in the number of organ transplantation procedures drives the growth of the immunosuppressant drugs market. As per the Global Observatory on Donation and Transplantation report, there was 139024 organ transplantation occurred in 2017. There is a significant increase in organ transplantation procedures in recent years.

The rising number of organ transplantation for kidneys, lungs, liver, pancreas, and other organs led to increasing demand for immunosuppressant drugs. Kidney is the most transplanted organ globally. In 2017, 36% of the total number of transplantations was for the kidney. Immunosuppressant drugs play a vital role in the success of organ transplant procedures.

Growing Prevalence of Autoimmune Disease Owing to Changing Lifestyles

Further, the growing prevalence of autoimmune disease owing to changing lifestyles stimulates the expansion of the market. The changes in dietary habits lead to stress, insufficient sleep, unhealthy eating habits, smoking, and different environmental factors that promote the rise in autoimmune diseases such as lupus, celiac disease, and others. The increasing advancements in tissue engineering and organ transplant techniques promote the growth of the immunosuppressant drugs market.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Immunosuppressant Drugs Market is Included in the Report for Free."

Rising Use of Tissue Engineering Create Several Opportunities

Additionally, increasing prevalence of chronic ailments and a rise in demand for organ replacement boost the expansion of the immunosuppressant drugs market. On the flip side, the high cost of the drugs restraints the growth of the immunosuppressant drugs market. Moreover, the adoption of advanced medical treatments and the rising use of tissue engineering create several opportunities for the growth of the immunosuppressant drugs market.

North America is Expected to Hold the Largest Share

Geographically, the global immunosuppressant drugs market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is expected to hold the largest share in the global immunosuppressant drugs market. The growing prevalence of autoimmune diseases and the increasing number of organ transplants in North America drive the growth of the immunosuppressant drugs market in the region. A study estimated that in the United States around 24 million people are having an autoimmune disease.

In addition, as of September 2019, the number of organ transplant candidates in the United States is 112947. Europe is expected to grow in the global immunosuppressant drugs market with a healthy CAGR over the forecast period. The rising number of transplants in Europe contributes to the expansion of the immunosuppressant drugs market in Europe. Asia-Pacific region has lucrative growth opportunities in the global immunosuppressant drugs market owing to the well-established healthcare industry and growing medical tourism in the region.

Get this Section as a Free Customization in the Report Along With 30% Discount on the Study. https://www.infiniumglobalresearch.com/reports/customization/18729

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Immunosuppressant Drugs Amidst COVID-19"

Immunosuppressant Drugs Market Coverage

Chapter - 1     Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2     Executive Summary

=> Eye Health Supplements Market Highlights

=> Eye Health Supplements Market Projection

=> Eye Health Supplements Market Regional Highlights

Chapter - 3     Global Eye Health Supplements Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Eye Health Supplements Market

Chapter - 4     Eye Health Supplements Market Macro Indicator Analysis

Chapter - 5     Global Eye Health Supplements Market by Application

=> Age Related Macular Degeneration (AMD)

=> Glaucoma

=> Diabetic Retinopathy

Chapter - 6     Global Eye Health Supplements Market by End User

=> Online Retailing

=> Offline Retailing Stores

Chapter - 7     Global Eye Health Supplements Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 8     Company Profiles and Competitive Landscape

=> Bausch + Lomb

=> Novartis International AG

=> Amway

=> Akorn Consumer Health

=> Butterflies Healthcare Ltd

=> Vitabiotics Ltd.

=> Herbalife International of America, Inc.

=> SUSS Technology Corp.

=> Pfizer Inc.

=> Allergan, Plc.

Chapter - 9     Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-immunosuppressant-drugs-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.